Assignee
PURINOMIA BIOTECH INC
US·1 granted patent·2 pending applications·0 citations·filing 2020–2024
Top patents by PatentIndex Score
3 records- 0156US2025059294A1Methods and compositions for promoting and potentiating t-cell mediated immune responses through adcc targeting of cd39 expressing cellsPURINOMIA BIOTECH INC·Filed 2024·Application pending·0 cites
- 0246US12098212B2Methods and compositions for promoting and potentiating T-cell mediated immune responses through ADCC targeting of CD39 expressing cellsPURINOMIA BIOTECH INC·Filed 2020·Granted Sep 24, 2024·0 cites·30 claims
- 0332US2024052061A1Methods and compositions for potentiating antitumoral immune responses through targeting of ntpdase3PURINOMIA BIOTECH INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when PURINOMIA BIOTECH INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →